133 related articles for article (PubMed ID: 12077255)
1. Key residues of a major cytochrome P4502D6 epitope are located on the surface of the molecule.
Ma Y; Thomas MG; Okamoto M; Bogdanos DP; Nagl S; Kerkar N; Lopes AR; Muratori L; Lenzi M; Bianchi FB; Mieli-Vergani G; Vergani D
J Immunol; 2002 Jul; 169(1):277-85. PubMed ID: 12077255
[TBL] [Abstract][Full Text] [Related]
2. Cytochrome P4502D6(193-212): a new immunodominant epitope and target of virus/self cross-reactivity in liver kidney microsomal autoantibody type 1-positive liver disease.
Kerkar N; Choudhuri K; Ma Y; Mahmoud A; Bogdanos DP; Muratori L; Bianchi F; Williams R; Mieli-Vergani G; Vergani D
J Immunol; 2003 Feb; 170(3):1481-9. PubMed ID: 12538711
[TBL] [Abstract][Full Text] [Related]
3. Establishment of a novel radioligand assay using eukaryotically expressed cytochrome P4502D6 for the measurement of liver kidney microsomal type 1 antibody in patients with autoimmune hepatitis and hepatitis C virus infection.
Ma Y; Gregorio G; Gäken J; Muratori L; Bianchi FB; Mieli-Vergani G; Vergani D
J Hepatol; 1997 Jun; 26(6):1396-402. PubMed ID: 9210629
[TBL] [Abstract][Full Text] [Related]
4. Sera of children with hepatitis C infection and anti-liver-kidney microsome-1 antibodies recognize different CYP2D6 epitopes than adults with LKM+/HCV+ sera.
Herzog D; Yamamoto AM; Jara P; Maggiore G; Sarles J; Alvarez F
J Pediatr Gastroenterol Nutr; 1999 Nov; 29(5):551-5. PubMed ID: 10554122
[TBL] [Abstract][Full Text] [Related]
5. Overlapping but distinct specificities of anti-liver-kidney microsome antibodies in autoimmune hepatitis type II and hepatitis C revealed by recombinant native CYP2D6 and novel peptide epitopes.
Klein R; Zanger UM; Berg T; Hopf U; Berg PA
Clin Exp Immunol; 1999 Nov; 118(2):290-7. PubMed ID: 10540193
[TBL] [Abstract][Full Text] [Related]
6. A major CYP2D6 autoepitope in autoimmune hepatitis type 2 and chronic hepatitis C is a three-dimensional structure homologous to other cytochrome P450 autoantigens.
Sugimura T; Obermayer-Straub P; Kayser A; Braun S; Loges S; Alex B; Lüttig B; Johnson EF; Manns MP; Strassburg CP
Autoimmunity; 2002 Dec; 35(8):501-13. PubMed ID: 12765476
[TBL] [Abstract][Full Text] [Related]
7. Immunological cross-reactivity to multiple autoantigens in patients with liver kidney microsomal type 1 autoimmune hepatitis.
Choudhuri K; Gregorio GV; Mieli-Vergani G; Vergani D
Hepatology; 1998 Nov; 28(5):1177-81. PubMed ID: 9794898
[TBL] [Abstract][Full Text] [Related]
8. Differences in immune recognition of cytochrome P4502D6 by liver kidney microsomal (LKM) antibody in autoimmune hepatitis and chronic hepatitis C virus infection.
Ma Y; Peakman M; Lobo-Yeo A; Wen L; Lenzi M; Gäken J; Farzaneh F; Mieli-Vergani G; Bianchi FB; Vergani D
Clin Exp Immunol; 1994 Jul; 97(1):94-9. PubMed ID: 8033426
[TBL] [Abstract][Full Text] [Related]
9. Differences in anti-LKM-1 autoantibody immunoreactivity to CYP2D6 antigenic sites between hepatitis C virus-negative and -positive patients.
Kitazawa E; Igarashi T; Kawaguchi N; Matsushima H; Kawashima Y; Hankins RW; Miyakawa H
J Autoimmun; 2001 Nov; 17(3):243-9. PubMed ID: 11712862
[TBL] [Abstract][Full Text] [Related]
10. Heterogeneity of liver/kidney microsomal antibody type 1 in autoimmune hepatitis and hepatitis C virus related liver disease.
Muratori L; Lenzi M; Ma Y; Cataleta M; Mieli-Vergani G; Vergani D; Bianchi FB
Gut; 1995 Sep; 37(3):406-12. PubMed ID: 7590439
[TBL] [Abstract][Full Text] [Related]
11. Multiple viral/self immunological cross-reactivity in liver kidney microsomal antibody positive hepatitis C virus infected patients is associated with the possession of HLA B51.
Bogdanos DP; Lenzi M; Okamoto M; Rigopoulou EI; Muratori P; Ma Y; Muratori L; Tsantoulas D; Mieli- Vergani G; Bianchi FB; Vergani D
Int J Immunopathol Pharmacol; 2004; 17(1):83-92. PubMed ID: 15000871
[TBL] [Abstract][Full Text] [Related]
12. A novel assay for detecting antibodies to cytochrome P4502D6, the molecular target of liver kidney microsomal antibody type 1.
Kerkar N; Ma Y; Hussain M; Muratori L; Targett C; Williams R; Bianchi FB; Mieli-Vergani G; Vergani D
J Immunol Methods; 1999 Mar; 223(2):227-35. PubMed ID: 10089101
[TBL] [Abstract][Full Text] [Related]
13. Liver/kidney microsomal antibody type 1 targets CYP2D6 on hepatocyte plasma membrane.
Muratori L; Parola M; Ripalti A; Robino G; Muratori P; Bellomo G; Carini R; Lenzi M; Landini MP; Albano E; Bianchi FB
Gut; 2000 Apr; 46(4):553-61. PubMed ID: 10716687
[TBL] [Abstract][Full Text] [Related]
14. Epitope mapping of cytochrome P4502D6 autoantigen in patients with chronic hepatitis C during alpha-interferon treatment.
Dalekos GN; Wedemeyer H; Obermayer-Straub P; Kayser A; Barut A; Frank H; Manns MP
J Hepatol; 1999 Mar; 30(3):366-75. PubMed ID: 10190716
[TBL] [Abstract][Full Text] [Related]
15. LKM1 autoantibodies in chronic hepatitis C infection: a case of molecular mimicry?
Marceau G; Lapierre P; Béland K; Soudeyns H; Alvarez F
Hepatology; 2005 Sep; 42(3):675-82. PubMed ID: 16037945
[TBL] [Abstract][Full Text] [Related]
16. Epitope spreading of the anti-CYP2D6 antibody response in patients with autoimmune hepatitis and in the CYP2D6 mouse model.
Hintermann E; Holdener M; Bayer M; Loges S; Pfeilschifter JM; Granier C; Manns MP; Christen U
J Autoimmun; 2011 Nov; 37(3):242-53. PubMed ID: 21795021
[TBL] [Abstract][Full Text] [Related]
17. Cytochrome P450IID6 recognized by LKM1 antibody is not exposed on the surface of hepatocytes.
Yamamoto AM; Mura C; De Lemos-Chiarandini C; Krishnamoorthy R; Alvarez F
Clin Exp Immunol; 1993 Jun; 92(3):381-90. PubMed ID: 7685669
[TBL] [Abstract][Full Text] [Related]
18. Identification and analysis of cytochrome P450IID6 antigenic sites recognized by anti-liver-kidney microsome type-1 antibodies (LKM1).
Yamamoto AM; Cresteil D; Boniface O; Clerc FF; Alvarez F
Eur J Immunol; 1993 May; 23(5):1105-11. PubMed ID: 7682958
[TBL] [Abstract][Full Text] [Related]
19. A new approach to cytochrome CYP2D6 antibody detection in autoimmune hepatitis type-2 (AIH-2) and chronic hepatitis C virus (HCV) infection: a sensitive and quantitative radioligand assay.
Yamamoto AM; Johanet C; Duclos-Vallee JC; Bustarret FA; Alvarez F; Homberg JC; Bach JF
Clin Exp Immunol; 1997 Jun; 108(3):396-400. PubMed ID: 9182882
[TBL] [Abstract][Full Text] [Related]
20. Polyclonal T-cell responses to cytochrome P450IID6 are associated with disease activity in autoimmune hepatitis type 2.
Ma Y; Bogdanos DP; Hussain MJ; Underhill J; Bansal S; Longhi MS; Cheeseman P; Mieli-Vergani G; Vergani D
Gastroenterology; 2006 Mar; 130(3):868-82. PubMed ID: 16530525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
